author-photo

Matthew Ch Ng

11

Papers

41

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma

2021 British Journal of Radiology
Show All
- Source
- Cite
- Save
Citations (0)
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study—An Asian Tertiary Cancer Center Experience

2021
Show All
- Source
- Cite
- Save
Citations (0)
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium

2021 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase II open-label, single-centre, non-randomized trial of Y90 transarterial radioembolization in combination with nivolumab in Asian patients with intermediate stage hepatocellular carcinoma: An immunological study of radioembolization in combination with anti-PD1 therapy in HCC.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Oxaliplatin (OX), chronomodulated capecitabine, and UGT1A1 genotype-directed dosing of irinotecan (IR) triplet chemotherapy (OXIRI) in patients (pts) with advanced pancreatic cancer (APC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
461 Individualized molecular profiling for allocation to clinical trials (impact) - experience from an Asian tertiary cancer centre

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A first-in-human (FIH) dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of intravenous BAL101553, a novel microtubule inhibitor, in adult patients with advanced solid tumors.

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)